These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 15232977)

  • 1. [Inherited combined hyperlipidemia (FKH)--revealing the genetic etiology is getting closer].
    Uusitupa M
    Duodecim; 2004; 120(10):1193-4. PubMed ID: 15232977
    [No Abstract]   [Full Text] [Related]  

  • 2. Screening for familial hypercholesterolemia: what is the most effective strategy?
    Daniels SR
    Nat Clin Pract Cardiovasc Med; 2008 Mar; 5(3):130-1. PubMed ID: 18059381
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of apolipoprotein E polymorphism on the response to lipid-lowering treatment with atorvastatin or fenofibrate.
    Christidis DS; Liberopoulos EN; Kakafika AI; Miltiadous GA; Cariolou M; Ganotakis ES; Mikhailidis DP; Elisaf MS
    J Cardiovasc Pharmacol Ther; 2006 Sep; 11(3):211-21. PubMed ID: 17056835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Supravalvular aortic stenosis and coronary ostial stenosis in homozygous familial hypercholesterolemia.
    Srimannarayana I; Varma RS; Satheesh S; Anilkumar R; Balachander J
    Indian Heart J; 2004; 56(2):152-4. PubMed ID: 15377140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [44. Normalizing blood lipids--with diet, sports and antilipemic agents].
    Faust M; Krone W
    MMW Fortschr Med; 2003 May; 145(19):I-X; quiz XI-XII. PubMed ID: 12813992
    [No Abstract]   [Full Text] [Related]  

  • 6. [Regression of arteriosclerosis. Results of animal experiments and human medical studies, results of drug therapy].
    Kaffarnik H; Zehner J
    Fortschr Med; 1985 May; 103(20):531-4. PubMed ID: 4007752
    [No Abstract]   [Full Text] [Related]  

  • 7. [Dyslipidemias].
    Duodecim; 2004; 120(24):2925-6. PubMed ID: 15700588
    [No Abstract]   [Full Text] [Related]  

  • 8. [Evaluation of a sulfomucopolysaccharide (3GS) in the treatment of hyperlipoproteinemias].
    Palmieri G; Perego M; Nazzari M; Casalini F
    Clin Ter; 1982 Jun; 101(6):603-14. PubMed ID: 7128029
    [No Abstract]   [Full Text] [Related]  

  • 9. Long-term survival of childhood coronary artery disease in a patient severely affected with familial hypercholesterolemia.
    Sibley C; McGann S; Stone NJ
    Am J Cardiol; 2004 Sep; 94(5):699-700. PubMed ID: 15342318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cystinosis--a treatable disease due to defective lysosomal transporter protein].
    Nuutinen M
    Duodecim; 2004; 120(5):593-8. PubMed ID: 15060996
    [No Abstract]   [Full Text] [Related]  

  • 11. Lipid-altering efficacy and safety of ezetimibe/simvastatin coadministered with extended-release niacin in patients with type IIa or type IIb hyperlipidemia.
    Guyton JR; Brown BG; Fazio S; Polis A; Tomassini JE; Tershakovec AM
    J Am Coll Cardiol; 2008 Apr; 51(16):1564-72. PubMed ID: 18420099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumorous xanthomas in a young male with familial hypercholesterolaemia.
    Rajput R; Bhansali A
    Arch Dis Child; 2006 Oct; 91(10):827. PubMed ID: 16990354
    [No Abstract]   [Full Text] [Related]  

  • 13. Failing to ENHANCE science.
    Farkouh ME; Bansilal S; Fuster V
    Nat Clin Pract Cardiovasc Med; 2008 Jul; 5(7):355. PubMed ID: 18580867
    [No Abstract]   [Full Text] [Related]  

  • 14. Genetics and preventive health care.
    Emery J; Barlow-Stewart K; Metcalfe SA; Sullivan D
    Aust Fam Physician; 2007 Oct; 36(10):808-11. PubMed ID: 17925900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Familial hypercholesterolemia: genetic predisposition to atherosclerosis.
    Engler MB
    Medsurg Nurs; 2004 Aug; 13(4):253-7. PubMed ID: 15384479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of fluvastatin + fenofibrate combination therapy and fluvastatin monotherapy in the treatment of combined hyperlipidemia, type 2 diabetes mellitus, and coronary heart disease: a 12-month, randomized, double-blind, controlled trial.
    Derosa G; Cicero AE; Bertone G; Piccinni MN; Ciccarelli L; Roggeri DE
    Clin Ther; 2004 Oct; 26(10):1599-607. PubMed ID: 15598476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Basal plasma concentrations of plant sterols can predict LDL-C response to sitosterol in patients with familial hypercholesterolemia.
    Fuentes F; López-Miranda J; García A; Pérez-Martínez P; Moreno J; Cofan M; Caballero J; Paniagua JA; Ros E; Pérez-Jiménez F
    Eur J Clin Nutr; 2008 Apr; 62(4):495-501. PubMed ID: 17440528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. APOE genotype, cholesterol level, lipid-lowering treatment, and dementia: the Three-City Study.
    Dufouil C; Richard F; Fiévet N; Dartigues JF; Ritchie K; Tzourio C; Amouyel P; Alpérovitch A
    Neurology; 2005 May; 64(9):1531-8. PubMed ID: 15883313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic determinants of cardiovascular disease risk in familial hypercholesterolemia.
    Jansen AC; van Aalst-Cohen ES; Tanck MW; Cheng S; Fontecha MR; Li J; Defesche JC; Kastelein JJ
    Arterioscler Thromb Vasc Biol; 2005 Jul; 25(7):1475-81. PubMed ID: 15879303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TaqIB polymorphism in CETP gene: the influence on incidence of cardiovascular disease in statin-treated patients with familial hypercholesterolemia.
    Mohrschladt MF; van der Sman-de Beer F; Hofman MK; van der Krabben M; Westendorp RG; Smelt AH
    Eur J Hum Genet; 2005 Jul; 13(7):877-82. PubMed ID: 15856070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.